Letter: Inequal digoxin tablets.
作者信息
Manninen V, Korhonen A
出版信息
Lancet. 1973 Dec 1;2(7840):1268. doi: 10.1016/s0140-6736(73)91011-8.
PMID:4128596
Abstract
摘要
相似文献
1
Letter: Inequal digoxin tablets.
Lancet. 1973 Dec 1;2(7840):1268. doi: 10.1016/s0140-6736(73)91011-8.
2
Quality control of digoxin tablets.地高辛片的质量控制
Postgrad Med J. 1974 Nov;50 Suppl 6:37-40.
3
The dissolution rate of digoxin tablets on the U.K. market: the scale of the problem.英国市场上地高辛片剂的溶出率：问题的规模。
Postgrad Med J. 1974 Nov;50 Suppl 6:52-5.
4
Editorial: Digoxin--the regulatory viewpoint.
Circulation. 1974 Mar;49(3):395-8. doi: 10.1161/01.cir.49.3.395.
5
Digoxin tablets.
Med Lett Drugs Ther. 1973 Nov 23;15(24):97-8.
6
Dissolution studies with single tablets of digoxin B.P.地高辛英国药典单片溶出度研究
Postgrad Med J. 1974 Nov;50 Suppl 6:43-7.
7
Letter: Digoxin tablets: a possible problem with biological availability.
Am Heart J. 1973 Nov;86(5):715. doi: 10.1016/0002-8703(73)90356-6.
8
Editorial: Bioavailability of drugs: focus on digoxin.社论：药物的生物利用度：聚焦地高辛。
Circulation. 1974 Mar;49(3):391-4. doi: 10.1161/01.cir.49.3.391.
9
Letter: Discrepancy between solution and bioavailability of digoxin tablets.信函：地高辛片溶液与生物利用度之间的差异
Lancet. 1975 Mar 15;1(7907):629. doi: 10.1016/s0140-6736(75)91907-8.
10
Recognition of variable bioavailability as an international problem: a review of the earlier studies.
Postgrad Med J. 1974 Nov;50 Suppl 6:14-8.
引用本文的文献
1
Variability in response to drugs.药物反应的变异性。
Br Med J. 1974 Oct 12;4(5936):91-4. doi: 10.1136/bmj.4.5936.91.
2
Bioavailability studies with Digoxin-Sandoz and Lanoxin.地高辛-山德士（Digoxin-Sandoz）和兰诺欣（Lanoxin）的生物利用度研究。
Eur J Clin Pharmacol. 1975 Jun 13;8(5):371-6. doi: 10.1007/BF00562665.
Zotero 插件